Pediatric B-cell Lymphoma, Unclassifiable, With Intermediate Features Between Those of Diffuse Large B-cell Lymphoma and Burkitt Lymphoma: A Report of Two Cases

참고문헌 (10)

1. Carbone A, "B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology", Hum Pathol, 41, pp.621~631 (2010)
2. Kluin PM, "WHO classification of tumours of haematopoietic and lymphoid tissues", pp.265~266 (2008), IARC Press
3. Liang X, "Gray zone lymphomas in pediatric patients", Pediatr Dev Pathol, 14, pp.57~63 (2011)
4. Lin P, "Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma", Cancer, 118, pp.1566~1573 (2012)
5. Salaverria I, "The gray zone between Burkitt’s lymphoma and diffuse large B-cell lymphoma from a genetics perspective", J Clin Oncol, 29, pp.1835~1843 (2011)
6. 안정열, "A Case of B-cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-cell Lymphoma and Burkitt Lymphoma in a Korean Child", Annals of Laboratory Medicine, 32(2), pp.162~166 (2012), 대한진단검사의학회
7. Lu B, "Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients", Leuk Lymphoma, 52, pp.2356~2364 (2011)
8. Reiter A, "Non-Hodgkin’s lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group", J Clin Oncol, 13, pp.359~372 (1995)
9. Cairo MS, "Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents", Blood, 109, pp.2736~2743 (2007)
10. Patte C, "Results of the randomized international FAB", LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients, 2007, pp.109, 2773~2780

관련 논문AI추천